LeadIQ logo
Learn more at LeadIQ.com

Insights

International Expansion Novocure has offices in multiple countries including Switzerland, the U.S., Canada, Germany, Japan, Poland, and Israel. This global presence provides opportunities for sales expansion into diverse markets.

Investment Influx Recent investments totaling over $500 million from firms like Seven Eight Capital, LP and Pharmakon Advisors, LP indicate investor confidence in Novocure's growth potential, which can be leveraged to drive sales initiatives.

Leadership Transition With a new CEO, Ashley Cordova, taking over from the retiring Asaf Danziger, there's a chance to capitalize on this change by aligning sales strategies with the company's vision under fresh leadership.

Clinical Development Expertise Dr. Ballas, the former Global Head of Clinical Development & Operations at Novocure, brings valuable expertise that can be utilized to connect with healthcare professionals and drive sales through informed clinical discussions.

Strong Financial Position Novocure's revenue in the range of $100 million to $1 billion and successful financing rounds demonstrate financial stability, providing a solid foundation for sales teams to negotiate deals confidently.

Similar companies to Novocure

Novocure Tech Stack

Novocure uses 8 technology products and services including Prezi, SAP Data Services, ABAP, and more. Explore Novocure's tech stack below.

  • Prezi
    Communication And Collaboration
  • SAP Data Services
    Data Integration
  • ABAP
    Enterprise
  • DocuSign
    Miscellaneous
  • WP Engine
    Platform As A Service
  • PHP
    Programming Languages
  • UPS
    Transportation And Fleet Management
  • FedEx
    Transportation And Fleet Management

Media & News

Novocure's Email Address Formats

Novocure uses at least 1 format(s):
Novocure Email FormatsExamplePercentage
FLast@novocure.comJDoe@novocure.com
95%
First.Last@novocure.comJohn.Doe@novocure.com
3%
FirstLast@novocure.comJohnDoe@novocure.com
1%
First@novocure.comJohn@novocure.com
1%

Frequently Asked Questions

Where is Novocure's headquarters located?

Minus sign iconPlus sign icon
Novocure's main headquarters is located at Park 6, 6039 Root D4 Root, Switzerland CH-6039 CH. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is Novocure's phone number?

Minus sign iconPlus sign icon
You can contact Novocure's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Novocure's stock symbol?

Minus sign iconPlus sign icon
Novocure is a publicly traded company; the company's stock symbol is NVCR.

What is Novocure's official website and social media links?

Minus sign iconPlus sign icon
Novocure's official website is novocure.com and has social profiles on LinkedIn.

How much revenue does Novocure generate?

Minus sign iconPlus sign icon
As of September 2024, Novocure's annual revenue reached $750M.

What is Novocure's NAICS code?

Minus sign iconPlus sign icon
Novocure's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Novocure have currently?

Minus sign iconPlus sign icon
As of September 2024, Novocure has approximately 1.4K employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: A. D.Chief Financial Officer: A. C.Chief Science Officer: M. G.. Explore Novocure's employee directory with LeadIQ.

What industry does Novocure belong to?

Minus sign iconPlus sign icon
Novocure operates in the Medical Equipment Manufacturing industry.

What technology does Novocure use?

Minus sign iconPlus sign icon
Novocure's tech stack includes PreziSAP Data ServicesABAPDocuSignWP EnginePHPUPSFedEx.

What is Novocure's email format?

Minus sign iconPlus sign icon
Novocure's email format typically follows the pattern of . Find more Novocure email formats with LeadIQ.

How much funding has Novocure raised to date?

Minus sign iconPlus sign icon
As of September 2024, Novocure has raised $100M in funding. The last funding round occurred on May 02, 2024 for $100M.

When was Novocure founded?

Minus sign iconPlus sign icon
Novocure was founded in 2000.
Novocure

Novocure

Medical Equipment ManufacturingSwitzerland, Switzerland1001-5000 Employees

We are a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of our innovative therapy, Tumor Treating Fields. Our commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma. We have ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, liver cancer and gastric cancer.

Headquartered in Switzerland, Novocure has U.S. operations in Portsmouth, New Hampshire and Chesterbrook, Pennsylvania. Additionally, Novocure has offices in Canada, Germany, Japan, Poland and Israel.

Section iconCompany Overview

Headquarters
Park 6, 6039 Root D4 Root, Switzerland CH-6039 CH
Phone number
Stock Symbol
NVCR
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2000
Employees
1001-5000

Section iconFunding & Financials

  • $100M

    Novocure has raised a total of $100M of funding over 7 rounds. Their latest funding round was raised on May 02, 2024 in the amount of $100M.

  • $100M$1B

    Novocure's revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $100M

    Novocure has raised a total of $100M of funding over 7 rounds. Their latest funding round was raised on May 02, 2024 in the amount of $100M.

  • $100M$1B

    Novocure's revenue is in the range of $100M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.